Skip to main content
Be The Investor
S&P 500
7,760.05+0.62%
Nasdaq Composite
26,718.91+1.11%
Dow Jones
52,833.19+0.64%
Russell 2000
2,780.79+0.15%
VIX
VIX
16.65-3.81%
Bitcoin
84,491.53+1.87%
Ethereum
2,495.77+2.01%
Solana
108.30+1.76%
Gold
4,151.00+0.20%
Silver
58.01+0.01%
Copper
6.573-0.47%
WTI Crude Oil
97.71-0.11%
US 10-Year Treasury Yield
5.147+0.57%
Home›Stocks›APMD
OverviewChartNewsFinancialsBusiness ModelCompetitorsStatisticsAnalysisEarningsValuationHoldersOptionsInsidersForecastCompareFAQ
APMD

Apnimed, Inc.

APMD
NASDAQUnited States flagUSReal-Time Price
$18.88USD
+0.36 (+1.97%)Today
BTI Score
Near Future
39
Long Term
44
BTI Fair Market Cap
Needs validation
High Risk

Apnimed, Inc. (APMD) Valuation

Is Apnimed, Inc. (APMD) overvalued or undervalued? BTI's fair-value estimate, DCF model and valuation multiples show the premium or discount to intrinsic worth.

Valuation Snapshot

P/E (TTM)
Trailing Price-to-Earnings
—
Forward P/E
Next 12 months estimate
—
PEG Ratio
P/E to Growth ratio
—
Price / Sales
Market cap vs. revenue
—
Price / Book
Market cap vs. book value
—
EV / EBITDA
Enterprise value multiple
—
Earnings Yield
Inverse of P/E
—
Revenue Growth
Year-over-year
—

Valuation Risk

Apnimed, Inc.'s valuation multiples are within a moderate range, suggesting the market is not pricing in excessive optimism. Investors should monitor growth execution relative to valuation.

Run Full Valuation Model
DCF, multiples, scenario analysis and AI fair value for APMD